#parkinsonsresearch

[lifesparktechnologies]

About Lifespark Technologies

Lifespark Technologies creates solutions for care in chronic neurological conditions such as Stroke, Parkinson's Disease . We are based at the Indian Institute of Technology - Bombay, India. Our solutions are designed for individuals, caregivers and the entire family; because these conditions don't just affect the lives of individuals.

Our solutions span the domains of AI/ML, medical devices, mobile applications and web applications. Lifespark Technologies aims to create the basic intelligence that will one day solve health issues at the earliest stage before they have damaging results. One day, a 60-year-old will look like today's 30-year-old.

Lifespark Technologies is among the top health-tech startups in the country and count many prominent business leaders and academics as our mentors. We have deployed our solutions in partnership with some of the largest healthcare organizations in India and are looking to establish ourselves as the go-to innovator globally.

Our Core Team Members :

CEO & Founder - Amey Desai

He has research experience in Machine Learning, Electronics, AI and their application in healthcare .

Research Head - Dr. Devendra Desai

​Dr. Desai heads the research team at Lifespark. With extensive experience in research and over a hundred publications, Dr. Desai's skills and medical acumen are instrumental to the research at Lifespark .

Chief Scientific Advisor & Mentor - Dr. Samit Chakrabarty

Dr. Chakrabarty is our chief scientific advisor and mentor. His expertise in Neurophysiology and multidisciplinary research provide deep and meaningful insights into the research at Lifespark .

Our Partners :

Awards and Recognition :

Shark Tank Season 3

Times of India

Prosus SICA Award 3rd place Winner

National Bio Entrepreneurship Competition Winner

[secondlife]

Celebrate the future at the 16th annual Sci-Fi Con in Second Life running from May 24th through June 4th with proceeds going to the Michael J. Fox Foundation in support of Parkinson's research.

Info ➡️ http://scificon.org

Destination ➡️ https://secondlife.com/destination/sci-fi-con

[symbiosisonlinepublishing]

Some of the most common neurological disorders include:

Stroke: A stroke is a sudden loss of brain function caused by a blood clot or bleeding in the brain.

Multiple sclerosis: Multiple sclerosis is a chronic disease that affects the central nervous system. It is characterized by inflammation and damage to the myelin sheath, which is a protective layer that surrounds nerve fibers.

Visit: https://symbiosisonlinepublishing.com/neurology/

[insightsbyskyquest]

Parkinson's Disease Drug Market Size, Share, and Growth Analysis 2031

Parkinson's Disease (PD) is a progressive neurodegenerative disorder that primarily affects motor functions. As the global population ages, the prevalence of PD is expected to rise, prompting significant interest in the Parkinson's disease drug market. This research provides an in-depth analysis of the market's size, share, and growth projections leading up to 2031. The Parkinson's disease drug market encompasses various therapeutic options, including dopaminergic therapies, non-dopaminergic therapies, and surgical interventions. Currently, the market is characterized by a diverse range of drugs that aim to manage symptoms rather than provide a cure.

Market Size and Share

Global Parkinson's Disease Drug Market size was valued at USD 4.61 billion in 2023 to USD 11.98 billion by 2031, growing at a CAGR of 12.1% in the forecast period (2024-2031). The growth is driven by an increasing prevalence of PD, advancements in drug development, and a growing focus on early diagnosis and treatment.

To Learn More About This Report, Request a Free Sample Copy - https://www.skyquestt.com/sample-request/parkinsons-disease-drug-market

Key Market Segments:

- Dopaminergic Therapies: This segment currently holds the largest share of the market, primarily driven by drugs like levodopa and dopamine agonists.

- Non-Dopaminergic Therapies: Emerging therapies, such as MAO-B inhibitors and glutamate antagonists, are gaining traction, particularly in early-stage treatment.

- Surgical Interventions: Deep brain stimulation (DBS) remains a crucial treatment option for advanced PD cases, contributing significantly to the market.

Factors Driving Growth

1. Aging Population: The risk of Parkinson's disease increases with age, leading to a growing patient population that demands effective treatment options.

2. Rising Awareness: Increased awareness about PD and its symptoms has led to earlier diagnosis and treatment initiation, further propelling market growth.

3. Innovative Therapies: Ongoing research and development efforts are yielding novel drug formulations and treatment modalities, enhancing patient outcomes.

4. Investment in Healthcare: Increased healthcare expenditure and investment in neurodegenerative disease research are providing a conducive environment for market growth.

Parkinson's Disease Drug Market Top Players Company Profiles - AbbVie Inc., Acorda Therapeutics Inc., Adamas Pharmaceuticals Inc., Biogen Inc., Britannia Pharmaceuticals Ltd., Denali Therapeutics Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, H. Lundbeck A/S, Impax Laboratories Inc., Intec Pharma Ltd., Ipsen S.A., Kyowa Hakko Kirin Co. Ltd., Merck & Co. Inc., Neurocrine Biosciences Inc., Novartis International AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., UCB S.A., Zambon S.p.A.

Read Parkinson's Disease Drug Market Report Today - https://www.skyquestt.com/report/parkinsons-disease-drug-market

The Parkinson's disease drug market is poised for significant growth over the next decade, driven by an aging population, increased awareness, and innovations in treatment. While challenges remain, ongoing research and development efforts are likely to enhance the landscape of PD management, ultimately improving the quality of life for millions affected by this debilitating condition. Stakeholders, including pharmaceutical companies and healthcare providers, must focus on developing accessible and effective treatment options to meet the growing demand in this market. Looking forward to 2031, the Parkinson's disease drug market is expected to evolve, with an emphasis on personalized medicine and combination therapies. As researchers uncover the complexities of PD, the focus will likely shift toward comprehensive treatment strategies that address both motor and non-motor symptoms, paving the way for more holistic patient care.

[lifesparktech]

Side Effects of Parkinson’s Medicines

Parkinson’s Disease results in many symptoms , some in early stages, which continue to get severe, and some develop as the disease progresses. Though, there is no cure to PD, there are many medications that are prescribed to reduce severity of the symptoms. Taking these medicines are essential to the quality of life of the PwPD as it allows them to carry on with their routine life as long as possible, and give them relief from pain and other disturbing symptoms.

Some of the medicines are known to create some side effects. This post talks about the same related information. We are going to follow the path of medicines that are commonly used by physicians, and accompanying them are narrated their commonly known side-effects.

Levodopa :

This is the most commonly used medication for PD.

In the early days of starting this medication, some PwPD feel nausea, but good news is that - many of them get over this the as body adjusts to the medicine. As Levodopa is absorbed through the gut, constipation or other stomach related problems occur for some.

After taking Levodopa for a long time, some people may have increased involuntary movements, in which case the dosage would have to be adjusted by the physician.

Other known side effects are:

1.​​ Confusion

2. Mood swings

3. Sleepiness, fainting or dizziness

4. Hallucinations and delusions

5. Impulsive and compulsive behaviour

Side effects of levodopa can sometimes be improved by changing your dose, the form of the drug or how often you take it. It may also be combined with other types of drugs.

Continue Reading 📖📖.....

Click on the Below Link 🔗 👇

[phonemantra-blog]

In a recent interview with People Magazine, legendary actor Michael J. Fox offered a glimpse into his vision for the future, specifically highlighting two prominent figures who he believes will continue to make a significant impact on the world in the years to come: pop superstar Taylor Swift and actor Ryan Reynolds. Beyond Entertainment: Recognizing Enduring Influence While discussing the 50th anniversary of People Magazine, Fox was asked about individuals he believes will make a lasting impact on society in the next half-century. His response transcended the realm of mere entertainment, showcasing his admiration for figures who leverage their platforms to create positive change. Michael J. Fox Hails Taylor Swift "I think she moves economies, she changes the way the world works, and that's amazing," Fox said of Taylor Swift. This powerful statement goes beyond catchy tunes and sold-out concerts. Fox acknowledges Swift's influence on social issues, particularly her vocal support for the LGBTQ community and her efforts to encourage voter registration among her massive fanbase. These actions have demonstrably influenced public discourse and social movements. Ryan Reynolds: More Than Just a Deadpool Fox continued his praise, highlighting Ryan Reynolds as another future leader. He lauded Reynolds' intelligence, talent, and business acumen, specifically noting his ability to "leverage things and make them succeed in other areas." Here, Fox goes beyond Reynolds' comedic charm and box office success. He recognizes Reynolds' entrepreneurial spirit and his ability to build successful ventures beyond acting. However, Fox doesn't stop at just professional accolades. He also emphasizes Reynolds' philanthropic endeavors, citing his environmental activism and his support for the Michael J. Fox Foundation for Parkinson's research. This highlights Reynolds' commitment to causes that extend beyond personal gain, demonstrating a genuine desire to make a positive difference. The Power of "Showing Up": Lessons from Advocacy Fox's reflections on Swift and Reynolds prompted him to explore the broader theme of celebrity activism. He ponders the question: "What is it about these people that everything they touch is gold?" His answer is refreshingly pragmatic. It's not just about fame or talent; it's about dedication and a willingness to take action. "You just show up and do it," says Fox. He emphasizes putting aside personal anxieties and focusing on the cause itself. This philosophy resonates through Fox's journey with Parkinson's disease. He openly shares how his advocacy work wasn't driven by a desire for public recognition. "I didn't think about it," he states. His motivation was simple and powerful: "I wanted to work on Parkinson's because I want a cure." Fox's personal story reinforces his point. His unwavering dedication to Parkinson's research has demonstrably accelerated progress in the field. He views Swift and Reynolds as kindred spirits, individuals who utilize their platforms for positive change without seeking accolades. A Future Shaped by Positive Influence Michael J. Fox's vision for the future is one where celebrities leverage their influence for social good. He recognizes the power that Taylor Swift and Ryan Reynolds wield, not just in entertainment, but in shaping a better world. Their commitment to social justice, environmental awareness, and scientific progress paints a promising picture for the decades ahead. This shift in focus, beyond mere entertainment, is what elevates Swift and Reynolds to the status of future titans of impact. Their actions inspire others to use their voices and resources to make a difference, ultimately shaping a brighter future for generations to come.

[omgculturemagazine]

Parkinson's Foundation Invests $2.8 Million in Research to Find a Cure

New Hope for Parkinson's Patients: Parkinson's Foundation Awards $2.8 Million in Grants #ParkinsonsResearch #ParkinsonsFoundation #ParkinsonsCure #ParkinsonsHope #ParkinsonsTreatments #ParkinsonsResearchGrants #NewHopeForParkinsonsPatients

Photo credit Lucas Vasques In an effort to accelerate cutting-edge Parkinson’s disease (PD) research, the Parkinson’s Foundation has invested $2.8 million in 30 grants. Researchers grant funds to the Foundation to study various aspects of PD in order to advance new therapies, treatments, and ultimately a cure for this debilitating neurological disease. A $1 million donation from Bill and Amy…

[thewitfire]

Unraveling the Complexities of Parkinson's Disease

Unraveling the Complexities of Parkinson's Disease.#ParkinsonsDisease #NeurologicalDisorders #ParkinsonsResearch #Genetics #StemCellTherapy #Neuroprotection #PersonalizedMedicine #EarlyDetection #NonMotorSymptoms #PatientSupport

Researchers are striving to unravel the complexities of Parkinson’s disease, which continues to impact millions of lives around the world. This progressive neurological disorder causes motor control and coordination problems as well as non-motor symptoms like depression or dementia. Photo by Karolina Grabowska on Pexels.com Understanding Parkinson’s Disease: What Causes It? Parkinson’s disease…

[viezec]

Facts Of #Parkinson's Disease And Stem Cell Therapy

To know more about Parkinson's visit https://www.viezec.com

[globalstemcellcare]

Fighting #Parkinson's Using Stem Cells

To know more about Parkinson visit, www.globalstemcellcare.com

[everydaydeeds]

Day 1546 - A friend of mine is also fundraising for Parkinson’s research and community support and I was happy to contribute toward her goal.

[bigfishsaab]

The truth is that, while people have eaten sea moss for years, scientists are only now beginning to research its medical benefits. May Prevent Parkinson’s Disease Parkinson’s Disease is the second-most-common degenerative disease found in older adults. Parkinson’s Disease affects movement, causing tremors, stiffness, and slowness of movement, and there is currently no cure. However, early research shows that sea moss may be able to slow the progression of Parkinson’s disease. In a study done with worms, extract from sea moss was shown to decrease the accumulation of α-synuclein and reduce stiffness and slowness of movement. This could mean promising things for people with Parkinson’s Disease. However, more research is needed to see if sea moss has the same effect on humans that it has on worms. 🦠🧬🌱👨🏾‍🌾 #diabetes #dementia #parkinsonsawarenessmonth #tremors #alzheimer #medical #parkinsonslifestyle #parkinsonsresearch #parkinsonsfighter #paralysis #dystonia #stayhome #strikethestroke #iwillagain #worldstrokecampaign #thinkfastactfast #fitness #recoveryourlife #pd #physiotherapy #startneurorehabilitation #parkinsonsfoundation #parkinsonssupport #parkinsonsdiseaseawareness #cbd #injury #parkinsonawareness #spine #spinalcord #paralysistreatment (at Dayton, Ohio) https://www.instagram.com/p/CI7EFgKF03o/?igshid=9o972r4x6081

[symbiosisonlinepublishing]

𝟏. 𝐍𝐞𝐫𝐯𝐨𝐮𝐬 𝐒𝐲𝐬𝐭𝐞𝐦 𝐂𝐨𝐦𝐩𝐨𝐧𝐞𝐧𝐭𝐬: Neurology encompasses the central nervous system (CNS), which includes the brain and spinal cord, and the peripheral nervous system (PNS), consisting of nerves that extend throughout the body. 𝟐. 𝐍𝐞𝐮𝐫𝐨𝐝𝐞𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐃𝐢𝐬𝐞𝐚𝐬𝐞𝐬: Examples include Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).

Visit: https://symbiosisonlinepublishing.com/neurology/

[teehugshop]

We are proud to say that a percentage of every product sold at Teehug is destined to a cause that we believe in! ⠀ Right now we are committed to help find a cure for Parkinson's Disease and we are donating the proceeds of each tshirt to Michael J. Fox Foundation . Also, the profits of the I AM LOVED Tank top go to The Trevor Project in Los Angeles (our LGBT cause of choice)⠀ *⠀ *⠀ *⠀ *⠀ *⠀ #donationsneeded #goodcauses #causes #socialcauses #parkinsonsdisease #parkinsons #parkinsonsawareness #parkinsonsawarenessmonth #parkinsonsresearch #lgbtqi #lgbtqcommunity #lgbtqpride #loveyoumore #loveyoubaby #loveyourself💕 #disabilityawareness #michaeljfoxfoundation #parkinsonsfoundation #teehugshop #teehugger https://www.instagram.com/p/CB0hkbNj_9T/?igshid=mir3aul4fysf

[lifesparktech]

Understanding Freezing of Gait (UnFOG)

Have you ever experienced a sudden feeling of being glued to the ground while trying to walk? If you are an individual suffering from Parkinson's disease(PD), you might be familiar with this frustrating sensation known as Freezing of gait (FOG). It's a common disabling motor symptom in PD that can seriously impact your quality of life.

FOG doesn't always happen the same way for everyone. It can show up in different situations and be triggered by various things. By understanding these different triggers, we can classify FOG into specific types, like freezing when trying to start walking, while turning, or freezing in tight spaces like doorways. Why does this matter? Well, personalization of treatment is very important for people with PD. Different types of FOG are associated with different mechanisms, and may be benfited with different treatment. By understanding the specific type of FOG a person experiences, doctors can choose the best treatment option for them. It means better care and improved quality of life for patients dealing with FOG.

The tools we currently have for measuring FOG fall short when it comes to classifying it into different subtypes. While tests like UPDRS, FOGQ and NFOGQ are helpful for screening, they don't record the details about how FOG presents in different situations. The Freezing of Gait Severity Tool does record activities and situations that trigger FOG. However, to really understand FOG and its subtypes, we need a tool that looks at not only physical aspects but also how the brain works in different situations. These tests can help narrow down which parts of the brain might be involved in causing FOG. That’s where UnFOG scale comes into play .

Learn more about UnFOG Click at ⬇️: